Minimal residual disease

Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome

L. B. Queiroz, Lima, B. D., Mazzeu, J. F., Camargo, R., Córdoba, M. S., Magalhães, I. Q., Martins-de-Sá, C., and Ferrari, I., Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome, vol. 12, pp. 4630-4638, 2013.

It has been reported that patients with Down syndrome (DS) frequently develop transient myeloproliferative disorder (TMD) and less commonly myeloid leukemia in DS (ML-DS). We examined the pathogenetic relationship of these conditions with somatic mutations of the GATA1 gene in children with both TMD and ML-DS.

Subscribe to Minimal residual disease